PhaseII study of nab-paclitaxel for elderly patients for the recurrence or Stage IIIB/IV with non-small cell lung cancer.
Not Applicable
- Conditions
- non-small cell lung cancer
- Registration Number
- JPRN-UMIN000011714
- Lead Sponsor
- Toho University Omori Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
1)Active double cancer 2)Active infectious disease in need of systemic administration of anti-bacterial drugs 3)Uncontrolled psychiatric disease 4)History of Severe drug allergies. 5)Pleural effusion, cardiac effusion, or cardiac effusion necessitating treatment. 6)The continuous case that receive it from head to foot of the steroid 7)Severe concurrent disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression free survival
- Secondary Outcome Measures
Name Time Method Overall survival, response rate, frequency and the degree of the adverse event,QO